Liu Youfang, Huang Xu
Department of Pulmonary and Critical Care Medicine, Center for Respiratory Diseases, China-Japan Friendship Hospital, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Beijing 100029, China. Corresponding author: Huang Xu, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Sep;35(9):968-974. doi: 10.3760/cma.j.cn121430-20221114-00982.
To systematically review safety and tolerance of enteral nutrition (EN) in a prone position, as well as the risks of increased gastric residual volume (GRV), vomiting, aspiration, and ventilator-associated pneumonia, and determine the ways to improve EN tolerance in patients with acute respiratory distress syndrome (ARDS).
Databases including PubMed, Embase and Wanfang Medical data of the English and Chinese literatures were retrieved up from January 1979 to January 2022 to collet the randomized controlled trial (RCT), non-RCT, and observational studies, concerning safety and tolerance of EN in a prone position with ARDS. All trials must have a minimum of two patient groups, one of which must be prone to ARDS and receive EN. Data searching extracting and quality evaluation were assessed by two reviewers independently. RevMan 5.4 software was used for analysis.
A total of 9 studies were included, including 2 RCTs, 2 non-RCTs, 4 prospective observational studies, and 1 retrospective observational study. The starting and increasing rate of EN were typically well tolerated in the prone position compared to the supine position in patients with ARDS, there was no significant increase in GRV (mL: 95 vs. 110), and the incidence of vomiting was not noticeably higher (0%-35% vs. 33%-57%). The incidence of ventilator-associated pneumonia with EN was not significantly higher in the prone position than in the supine position in patients with ARDS (6%-35% vs. 15%-24%). Aspiration occurred at a similar rate in patients in the nasogastric tube and post-pyloric feeding groups with EN in patients with ARDS in the prone position (22% vs. 20%). EN tolerability with nasogastric and nasojejunal tubes was similar in prone positions, with no significant difference in EN intolerance incidences (15% vs. 22%). Head elevation (30 degree angle-45 degree angle) improved EN tolerance in the prone position in patients with ARDS, thereby increasing the early EN dose [odds ratio (OR) = 0.48, 95% confidence interval (95%CI) was 0.22-1.08, P = 0.08]. Additionally, prophylactic application of gastrointestinal motility drugs, such as erythromycin, at the start of EN in a prone position significantly improved patients' EN tolerance (OR = 1.14, 95%CI was 0.63-2.05, P = 0.67).
The use of gastric tube for EN in prone position and similar feeding speed to the supine position in patients with ARDS is safe and well tolerated. The initiation and dosing of EN should not be delayed in the prone position. EN tolerance may be increased by elevating the head of the bed during enteral feeding in a prone position, and gastrointestinal motility medications should be promptly administered with EN initiation in patients with ARDS.
系统评价急性呼吸窘迫综合征(ARDS)患者俯卧位肠内营养(EN)的安全性和耐受性,以及胃残余量(GRV)增加、呕吐、误吸和呼吸机相关性肺炎的风险,并确定提高ARDS患者EN耐受性的方法。
检索1979年1月至2022年1月期间包括PubMed、Embase和万方医学数据在内的中英文文献数据库,收集关于ARDS患者俯卧位EN安全性和耐受性的随机对照试验(RCT)、非RCT和观察性研究。所有试验必须至少有两个患者组,其中一组必须为ARDS患者且接受EN。由两名 reviewers 独立进行数据检索、提取和质量评估。使用RevMan 5.4软件进行分析。
共纳入9项研究,包括2项RCT、2项非RCT、4项前瞻性观察性研究和1项回顾性观察性研究。与仰卧位相比,ARDS患者俯卧位EN的起始和增加速率通常耐受性良好,GRV无显著增加(mL:95 vs. 110),呕吐发生率也无明显升高(0%-35% vs. 33%-57%)。ARDS患者俯卧位EN时呼吸机相关性肺炎的发生率并不显著高于仰卧位(6%-35% vs. 15%-24%)。ARDS患者俯卧位时鼻胃管和幽门后喂养组EN患者的误吸发生率相似(22% vs. 20%)。俯卧位时鼻胃管和鼻空肠管的EN耐受性相似,EN不耐受发生率无显著差异(15% vs. 22%)。床头抬高(30度角-45度角)可提高ARDS患者俯卧位时的EN耐受性,从而增加早期EN剂量[比值比(OR)=0.48,95%置信区间(95%CI)为0.22-1.08,P = 0.08]。此外,在俯卧位EN开始时预防性应用胃肠动力药物,如红霉素,可显著提高患者的EN耐受性(OR = 1.14,95%CI为0.63-2.05,P = 0.67)。
ARDS患者俯卧位使用胃管进行EN且喂养速度与仰卧位相似是安全且耐受性良好的。俯卧位时EN的起始和给药不应延迟。俯卧位肠内喂养时抬高床头可能会增加EN耐受性,ARDS患者EN开始时应及时给予胃肠动力药物。